Research graph
References from Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12‐month safety report. Local targets link to admitted publications; unresolved targets remain external evidence.
10.7326/0003-4819-85-5-601
10.7326/0003-4819-85-5-601 · External reference
10.1210/jc.2003-031719
10.1210/jc.2003-031719 · External reference
10.1186/1477-7525-7-75
10.1186/1477-7525-7-75 · External reference
10.1210/jc.2009-2354
10.1210/jc.2009-2354 · External reference
10.1210/jc.2010-3012
10.1210/jc.2010-3012 · External reference
10.1016/j.eururo.2006.10.061
10.1016/j.eururo.2006.10.061 · External reference
10.1111/j.1743-6109.2011.02288.x
10.1111/j.1743-6109.2011.02288.x · External reference
10.1111/j.1743-6109.2006.00270.x
10.1111/j.1743-6109.2006.00270.x · External reference
10.1016/j.ucl.2007.08.006
10.1016/j.ucl.2007.08.006 · External reference
10.1517/14728222.10.3.445
10.1517/14728222.10.3.445 · External reference
10.1111/jsm.12059
10.1111/jsm.12059 · External reference
10.1073/pnas.0407183102
10.1073/pnas.0407183102 · External reference
10.1530/eje-11-0447
10.1530/eje-11-0447 · External reference
10.1016/0009-8981(80)90469-6
10.1016/0009-8981(80)90469-6 · External reference
10.1210/jcem.87.2.8201
10.1210/jcem.87.2.8201 · External reference
10.1111/j.1743‐6109.2012.02808.x
10.1111/j.1743‐6109.2012.02808.x · External reference
10.1002/1097-0142(19820401)49:7<1373::aid-cncr2820490712>3.0.co;2-g
10.1002/1097-0142(19820401)49:7<1373::aid-cncr2820490712>3.0.co;2-g · External reference
10.1111/j.1439-0272.2011.01192.x
10.1111/j.1439-0272.2011.01192.x · External reference
10.1182/blood-2005-06-2373
10.1182/blood-2005-06-2373 · External reference
Priapism following testosterone therapy for delayed puberty
1989 · External reference
10.1111/j.1600-0609.1970.tb01919.x
10.1111/j.1600-0609.1970.tb01919.x · External reference
Tolerability of intramuscular injections of testosterone ester in oil vehicle
10.1093/oxfordjournals.humrep.a136051 · 1995 · External reference
10.1097/00043426-199911000-00013
10.1097/00043426-199911000-00013 · External reference
10.1016/s0306-4522(01)00420-1
10.1016/s0306-4522(01)00420-1 · External reference
10.1097/01.ju.0000087608.07371.ca
10.1097/01.ju.0000087608.07371.ca · External reference
10.1111/j.1743-6109.2010.01765.x
10.1111/j.1743-6109.2010.01765.x · External reference
10.1210/en.2003-1699
10.1210/en.2003-1699 · External reference
10.1053/meta.2000.8625
10.1053/meta.2000.8625 · External reference
10.1007/s11934-012-0258-9
10.1007/s11934-012-0258-9 · External reference
10.1016/s0022-3476(75)80662-7
10.1016/s0022-3476(75)80662-7 · External reference
10.1016/s0140-6736(81)90525-0
10.1016/s0140-6736(81)90525-0 · External reference
10.1136/pgmj.63.736.95
10.1136/pgmj.63.736.95 · External reference
The mechanism of low testosterone levels in homozygous sickle‐cell disease
1994 · External reference
10.2164/jandrol.110.011890
10.2164/jandrol.110.011890 · External reference
Zinc deficiency in sickle cell disease
10.1093/clinchem/21.4.582 · 1975 · External reference
10.1016/s0090-4295(97)00238-0
10.1016/s0090-4295(97)00238-0 · External reference
10.1155/2011/471584
10.1155/2011/471584 · External reference
10.1111/j.1464-410x.2007.06756.x
10.1111/j.1464-410x.2007.06756.x · External reference
Unresolved reference
2001 · External reference
Testosterone deficiency and extreme retardation of puberty in homozygous sickle‐cell disease
1995 · External reference
10.1515/jpem.1995.8.3.199
10.1515/jpem.1995.8.3.199 · External reference
10.1111/j.1743-6109.2005.00094.x
10.1111/j.1743-6109.2005.00094.x · External reference
10.2164/jandrol.109.009597
10.2164/jandrol.109.009597 · External reference
10.1017/s0033291798006667
10.1017/s0033291798006667 · External reference
10.1007/s00345-006-0120-0
10.1007/s00345-006-0120-0 · External reference
10.1016/s0022-5347(05)67836-6
10.1016/s0022-5347(05)67836-6 · External reference
10.1016/s0002-9343(88)80364-4
10.1016/s0002-9343(88)80364-4 · External reference
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men
2012 · External reference
Nitric oxide mediated erectile activity is a testosterone dependent event: a rat erection model
1995 · External reference
